Get the Stockscreener App
79.62
3.15%
-2.59
After Hours:
79.88
0.26
+0.33%
Netflix Inc stock is traded at $79.62, with a volume of 40.68M.
It is down -3.15% in the last 24 hours and down -11.00% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$82.21
Open:
$81.96
24h Volume:
40.68M
Relative Volume:
0.90
Market Cap:
$336.17B
Revenue:
$45.27B
Net Income/Loss:
$10.98B
P/E Ratio:
31.51
EPS:
2.5272
Net Cash Flow:
$9.46B
1W Performance:
-0.67%
1M Performance:
-11.00%
6M Performance:
-34.65%
1Y Performance:
-21.02%
1-Day Range:
$79.45
$82.48
1-Week Range:
$79.45
$84.66
52-Week Range:
$79.22
$134.12
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, WBD, LYV, FOXA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
79.62 | 347.10B | 45.27B | 10.98B | 9.46B | 2.5272 |
|
DIS
Walt Disney Co
|
108.12 | 194.80B | 95.62B | 13.27B | 7.06B | 6.7872 |
|
WBD
Warner Bros Discovery Inc
|
27.99 | 68.93B | 37.87B | 356.00M | 4.13B | 0.1876 |
|
LYV
Live Nation Entertainment Inc
|
151.11 | 34.67B | 24.57B | 532.09M | 1.59B | 1.37 |
|
FOXA
Fox Corporation
|
61.11 | 26.96B | 16.47B | 2.07B | 2.67B | 4.4433 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-26 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-26 | Reiterated | Deutsche Bank | Hold |
| Jan-21-26 | Reiterated | Goldman | Neutral |
| Jan-21-26 | Reiterated | Guggenheim | Buy |
| Jan-21-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-21-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-21-26 | Reiterated | Needham | Buy |
| Jan-21-26 | Reiterated | Oppenheimer | Outperform |
| Jan-21-26 | Reiterated | Piper Sandler | Overweight |
| Jan-21-26 | Reiterated | Pivotal Research Group | Hold |
| Jan-21-26 | Reiterated | Rosenblatt | Neutral |
| Jan-21-26 | Reiterated | Rothschild & Co Redburn | Buy |
| Jan-21-26 | Reiterated | TD Cowen | Buy |
| Jan-21-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Wolfe Research | Outperform |
| Jan-12-26 | Initiated | HSBC Securities | Buy |
| Jan-09-26 | Reiterated | Goldman | Neutral |
| Dec-08-25 | Downgrade | Pivotal Research Group | Buy → Hold |
| Dec-08-25 | Downgrade | Rosenblatt | Buy → Neutral |
| Nov-18-25 | Reiterated | Barclays | Equal Weight |
| Oct-31-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-07-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-17-25 | Upgrade | Loop Capital | Hold → Buy |
| Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-25 | Reiterated | Goldman | Neutral |
| Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
| Jun-12-25 | Reiterated | Oppenheimer | Outperform |
| Jun-03-25 | Reiterated | Jefferies | Buy |
| May-30-25 | Reiterated | BofA Securities | Buy |
| May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-25 | Reiterated | Barclays | Equal Weight |
| Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
| Apr-21-25 | Reiterated | Guggenheim | Buy |
| Apr-21-25 | Reiterated | JP Morgan | Overweight |
| Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-21-25 | Reiterated | MoffettNathanson | Buy |
| Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-21-25 | Reiterated | Oppenheimer | Outperform |
| Apr-21-25 | Reiterated | Piper Sandler | Overweight |
| Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-25 | Reiterated | Wells Fargo | Overweight |
| Apr-17-25 | Resumed | Piper Sandler | Overweight |
| Mar-27-25 | Initiated | FBN Securities | Outperform |
| Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
| Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-22-25 | Reiterated | Oppenheimer | Outperform |
| Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
| Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
| Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
| Jan-15-25 | Reiterated | Oppenheimer | Outperform |
| Jan-08-25 | Reiterated | Goldman | Neutral |
| Jan-06-25 | Reiterated | Argus | Buy |
| Jan-03-25 | Reiterated | The Benchmark Company | Sell |
| Dec-19-24 | Reiterated | UBS | Buy |
| Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
| Dec-16-24 | Reiterated | Oppenheimer | Outperform |
| Dec-11-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-18-24 | Reiterated | Needham | Buy |
| Oct-18-24 | Reiterated | Oppenheimer | Outperform |
| Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-16-24 | Reiterated | Loop Capital | Buy |
| Oct-11-24 | Reiterated | Guggenheim | Buy |
| Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
| Oct-10-24 | Reiterated | Oppenheimer | Outperform |
| Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-05-24 | Initiated | China Renaissance | Hold |
| Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
| Jul-17-24 | Reiterated | Guggenheim | Buy |
| Jul-16-24 | Reiterated | The Benchmark Company | Sell |
| Jul-15-24 | Reiterated | BofA Securities | Buy |
| Jul-12-24 | Reiterated | JP Morgan | Overweight |
| Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-09-24 | Reiterated | TD Cowen | Buy |
| Jul-02-24 | Reiterated | Argus | Buy |
| May-28-24 | Reiterated | Evercore ISI | Outperform |
| Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-19-24 | Upgrade | Needham | Hold → Buy |
| Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
| Apr-15-24 | Reiterated | Deutsche Bank | Hold |
| Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
| Apr-12-24 | Reiterated | Piper Sandler | Neutral |
| Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
| Mar-25-24 | Reiterated | Citigroup | Neutral |
| Mar-12-24 | Reiterated | Jefferies | Buy |
| Mar-11-24 | Reiterated | Oppenheimer | Outperform |
| Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
| Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
| Jan-24-24 | Reiterated | BofA Securities | Buy |
| Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
| Jan-24-24 | Reiterated | Evercore ISI | Outperform |
| Jan-24-24 | Reiterated | Goldman | Neutral |
| Jan-24-24 | Reiterated | Guggenheim | Buy |
| Jan-24-24 | Reiterated | JP Morgan | Overweight |
| Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
| Jan-24-24 | Reiterated | Oppenheimer | Outperform |
| Jan-24-24 | Reiterated | Piper Sandler | Neutral |
| Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
| Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
| Jan-24-24 | Reiterated | TD Cowen | Outperform |
| Jan-24-24 | Reiterated | UBS | Buy |
| Jan-24-24 | Reiterated | Wells Fargo | Overweight |
| Sep-18-23 | Reiterated | Evercore ISI | Outperform |
| Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
| Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-17-23 | Reiterated | Deutsche Bank | Buy |
| Jul-13-23 | Reiterated | JP Morgan | Overweight |
| Jul-12-23 | Reiterated | UBS | Buy |
| Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-29-23 | Reiterated | Citigroup | Buy |
| Jun-28-23 | Reiterated | Oppenheimer | Outperform |
| Jun-13-23 | Reiterated | BofA Securities | Buy |
| Jun-13-23 | Reiterated | Guggenheim | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Jefferies | Buy |
| Apr-19-23 | Reiterated | Piper Sandler | Neutral |
| Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
| Apr-19-23 | Reiterated | Rosenblatt | Neutral |
| Apr-19-23 | Upgrade | UBS | Neutral → Buy |
| Apr-11-23 | Resumed | Robert W. Baird | Neutral |
| Jan-23-23 | Reiterated | Argus | Buy |
| Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
| Jan-20-23 | Reiterated | Deutsche Bank | Buy |
| Jan-20-23 | Reiterated | Evercore ISI | Outperform |
| Jan-20-23 | Reiterated | Goldman | Sell |
| Jan-20-23 | Reiterated | Guggenheim | Buy |
| Jan-20-23 | Reiterated | Jefferies | Buy |
| Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
| Jan-20-23 | Reiterated | Oppenheimer | Outperform |
| Jan-20-23 | Reiterated | Piper Sandler | Neutral |
| Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
| Jan-20-23 | Reiterated | The Benchmark Company | Sell |
| Jan-20-23 | Reiterated | Wedbush | Outperform |
| Jan-20-23 | Reiterated | Wolfe Research | Outperform |
| Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-04-23 | Initiated | New Street | Neutral |
| Dec-29-22 | Upgrade | CFRA | Sell → Buy |
| Dec-14-22 | Reiterated | Jefferies | Hold |
| Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
| May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
| Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
| Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-20-22 | Upgrade | Needham | Underperform → Hold |
| Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
| Apr-20-22 | Downgrade | Stifel | Buy → Hold |
| Apr-20-22 | Downgrade | UBS | Buy → Neutral |
| Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-19-22 | Initiated | Rosenblatt | Neutral |
| Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
| Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-22 | Reiterated | BofA Securities | Buy |
| Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-22 | Reiterated | Cowen | Outperform |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Goldman | Neutral |
| Jan-21-22 | Reiterated | Guggenheim | Buy |
| Jan-21-22 | Reiterated | JP Morgan | Overweight |
| Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
| Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-21-22 | Reiterated | Oppenheimer | Outperform |
| Jan-21-22 | Reiterated | Piper Sandler | Overweight |
| Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
| Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-21-22 | Downgrade | Truist | Buy → Hold |
| Jan-21-22 | Reiterated | UBS | Buy |
| Jan-21-22 | Reiterated | Wolfe Research | Outperform |
| Dec-15-21 | Reiterated | The Benchmark Company | Sell |
| Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-29-21 | Reiterated | The Benchmark Company | Sell |
| Sep-13-21 | Initiated | Goldman | Neutral |
| Sep-08-21 | Reiterated | JP Morgan | Overweight |
| Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
| Jul-21-21 | Reiterated | Credit Suisse | Outperform |
| Jul-21-21 | Reiterated | Deutsche Bank | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-25-21 | Initiated | Edward Jones | Hold |
| May-19-21 | Resumed | Jefferies | Buy |
| Apr-21-21 | Resumed | Oppenheimer | Outperform |
| Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-21 | Upgrade | Stifel | Hold → Buy |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Piper Sandler | Overweight |
| Mar-25-21 | Reiterated | The Benchmark Company | Sell |
| Mar-23-21 | Upgrade | Argus | Hold → Buy |
| Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
| Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-21 | Reiterated | The Benchmark Company | Sell |
| Jan-20-21 | Upgrade | UBS | Neutral → Buy |
| Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
| Oct-21-20 | Reiterated | Bernstein | Outperform |
| Oct-21-20 | Reiterated | Jefferies | Buy |
| Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-21-20 | Reiterated | Oppenheimer | Outperform |
| Oct-21-20 | Reiterated | Piper Sandler | Overweight |
| Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
| Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-21-20 | Reiterated | The Benchmark Company | Sell |
| Oct-21-20 | Reiterated | Wedbush | Underperform |
| Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
| Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
| Oct-14-20 | Reiterated | Goldman | Buy |
| Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-28-20 | Reiterated | The Benchmark Company | Sell |
| Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-20 | Resumed | Raymond James | Mkt Perform |
| Sep-04-20 | Reiterated | The Benchmark Company | Sell |
| Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Insider Sell: Gregory Peters Sells 27,312 Shares of Netflix Inc (NFLX) - GuruFocus
Insider Selling: Netflix (NASDAQ:NFLX) CEO Sells 27,312 Shares of Stock - MarketBeat
‘The Walking Dead’ Streaming Renewal Talks Underway As Netflix Deal Nears End, AMC Networks CEO Kristin Dolan Says - IMDb
Netflix (NFLX) Options Show Mixed Sentiment Amid Stock Dip - GuruFocus
Warner Bros. Discovery board faces pressure as activist investor threatens to vote no on Netflix deal - Los Angeles Times
3 Reasons to Buy Netflix Stock Now - Yahoo Finance
Ancora threatens proxy fight over Warner Bros Discovery’s acquisition deal with Netflix - Yahoo! Finance Canada
Netflix appeals French Community's "disproportionate" production support rules in court - belganewsagency.eu
Activist investor Ancora publicly opposes the WBD-Netflix deal - Yahoo Finance
Paramount ratchets up competition for Warner Bros. but still falls short - Axios
Activist Investor Pushes Warner to Walk Away From Netflix Deal - The Wall Street Journal
Warner Bros. Gets an Activist. Why It Doesn’t Like the Netflix Deal. - Barron's
Small Warner Bros. Discovery Shareholder Blasts ‘Flawed, Inferior’ Netflix Offer and Backs Paramount’s Hostile Bid — but Will It Matter? - Yahoo Finance UK
Activist Ancora Urges Warner Board to Reject Netflix Bid - Bloomberg.com
Activist Investor Slams WBD For Rushing Into “Flawed” Netflix Deal, Tells Board To Engage With Paramount As Temperature Rises - Yahoo! Finance Canada
Netflix stock ticks up before the bell as activist targets Warner deal; what to watch next - Bez Kabli
‘This is a Sledgehammer,’ Says Investor About Netflix Stock - TipRanks
Activist Investor Puts Heat on Warner Bros. Discovery to Reject Netflix Offer For “Inferior Value” - The Hollywood Reporter
Is Netflix’s 10% Dip a Buying Opportunity or a Warning Sign? - Yahoo Finance
Activist Ancora fund moves to block Netflix takeover of Warner studios - Euronews.com
Netflix (NFLX) Plunged Due to Investors’ Concerns Over Acquisition Pricing - Yahoo Finance
German Voice Actors Boycott Netflix Over AI Training Clause in New Contracts - BABL AI
Warner Bros. Gets an Activist. What It Means for the Netflix Takeover Battle. - Barron's
Ancora Capital builds stake in Warner Bros, plans to oppose Netflix deal By Reuters - Investing.com
Ancora Capital builds stake in Warner Bros, plans to oppose Netflix deal - Yahoo Finance
Activist investor Ancora to oppose Netflix-Warner Bros deal, backs Paramount bid - Reuters
Netflix stock is down 15%. Should you buy the dip? - MSN
Netflix Stock Is Down 15%. Should You Buy the Dip? - Nasdaq
Activist investor increases WBD holding, preparing to ‘oppose Netflix deal’ - TVBEurope
25,303 Shares in Netflix, Inc. $NFLX Acquired by Caprock Group LLC - MarketBeat
Warner Bros. Gets an Activist, Report Says. What It Means for the Netflix Takeover Battle. - Barron's
Netflix Inc. (NASDAQ:NFLX) Emerges as a Prime GARP Stock with Strong Growth and Sound Fundamentals - Chartmill
I Predicted Netflix Would Crush the S&P 500 From 2026 Through 2030, but It's Already Down 12% This Year. Is Netflix Still a Buy? - Nasdaq
Netflix's Warner Bros. Acquisition Sparks Stock Volatility - Intellectia AI
Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB - The Wall Street Journal
Netflix, Inc. $NFLX Shares Sold by Rhumbline Advisers - MarketBeat
Netflix (NFLX) Stock; Slight Uptick as Paramount Boosts Warner Bros Bid - CoinCentral
Netflix, Inc. $NFLX Shares Acquired by ING Groep NV - MarketBeat
Is Netflix stock your ticket to becoming a millionaire? - MSN
Is Netflix Stock Your Ticket to Becoming a Millionaire? - AOL.com
Warner Bros Discovery Deal Drama Deepens: Activist Investor Ancora Plans To Oppose Netflix Offer As Paramount Sweetens Bid - Benzinga
Shin Hye-sun and Na In-woo are reuniting for a new Netflix romantic comedy series, "Love O’Clock," which is set to put a chaotic twist on the body-swap trope. Read the story in the link in the comments section. - facebook.com
Paramount Skydance Sweetens Warner Bros. Bid with Netflix Fee Cover, PSKY Stock Surges - TipRanks
Paramount Skydance Bid Puts Netflix Warner Bros Deal And Valuation In Focus - Yahoo Finance
Activist investor takes aim at Warner Bros deal with Netflix - Financial Times
Warner Bros-Netflix Deal: Activist Reportedly Builds $200M Stake In WBD, Nudges It To Review Paramount’s Bid Thoroughly - Stocktwits
Activist investor Ancora pushes Warner Bros to walk away from Netflix deal, WSJ reports By Reuters - Investing.com
Activist Ancora builds $200 mln stake in Warner, opposes Netflix deal- WSJ - Investing.com
Netflix Denies 'The Wonderfools' May 15 Release - 조선일보
Activist Investor Ancora Is Said to Build Stake in Warner Bros. - Bloomberg.com
Paramount sweetens Warner Bros bid with offer to pay Netflix break-up cost, other fees - The Detroit News
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.67%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):